The trial of seven health care professionals accused of negligence in the death of soccer great Diego Maradona resumed on ...

Subdural hematoma with mild symptoms progressed significantly less often when treated with middle meningeal artery (MMA) embolization compared with observation alone, new results from the second phase ...

BOSTON, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Balt, Inc., a global technology leader in neurovascular devices, today announced the Premarket Approval (PMA) of the Squid™ liquid embolic agent. Squid is ...

Background: Accurate assessment of subdural hematoma (SDH) thickness is critical for clinical decision-making. While non-contrast computed tomography (CT) remains the gold standard, Hyperfine portable ...

This story has been udpated. Drivers who speed down Route 66 on the border of Middletown and Middlefield are getting hit with an automatic $50 fine. The second time they’re caught in a month costs $75 ...

1. Across 18 U.S. centers, preference for surgical or conservative management for acute subdural hematoma (ASDH) varied widely but did not affect six-month functional outcomes. Evidence Rating Level: ...

Walk by 64 Pratt St. and there’s little sign that major construction in full swing, so much so that some have wondered whether a new residence hall for the University of Connecticut will actually be ...

Earlier this month, Medtronic received a new approval from the FDA for its decades-old liquid embolic system, extending its use to treat certain kinds of internal brain bleeds. Now, Johnson & Johnson ...

- TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery. - ...

Sometimes the darkest products (names) bring a bright spot of news to their developers, as the U.S. FDA clearance for Galway, Ireland-based Medtronic plc's Onyx liquid embolic system demonstrates.

Johnson & Johnson MedTech is expanding its stroke-focused R&D in Ireland, building on previous investments and coming on the heels of a new innovation center that was completed earlier this year in ...

Chronic subdural hematoma (CSDH) is one of the most common neurosurgical conditions, particularly among the elderly, with an annual incidence ranging from 1.7 to 20.6 per 100,000 people. As the global ...